Attached files
file | filename |
---|---|
8-K - FORM 8-K - MEDTRONIC INC | c56981e8vk.htm |
EX-1.1 - EX-1.1 - MEDTRONIC INC | c56981exv1w1.htm |
EX-4.1 - EX-4.1 - MEDTRONIC INC | c56981exv4w1.htm |
Exhibit 99.1
NEWS RELEASE |
Contacts: | ||||
Chuck Grothaus | Jeff Warren | |||
Public Relations | Investor Relations | |||
763-505-2614 | 763-505-2696 |
FOR IMMEDIATE RELEASE
MEDTRONIC ANNOUNCES PUBLIC OFFERING OF SENIOR NOTES
MINNEAPOLIS March 11, 2010 Medtronic, Inc. (NYSE:MDT) today announced a registered offering
of $1.25 billion of its 3.0 percent Senior Notes due 2015, $1.25 billion of its 4.45 percent Senior
Notes due 2020 and $500 million of its 5.55 percent Senior Notes due 2040 (collectively, the
Notes). Medtronic intends to use the net proceeds for working capital and general corporate
purposes, which may include the repayment of its indebtedness.
The Notes will be senior unsecured and unsubordinated obligations of Medtronic and will rank
equally with all of Medtronics existing and future senior unsecured debt and senior to all of
Medtronics subordinated debt.
This press release is not an offer to sell or the solicitation of an offer to buy nor shall there
be any sale of such Notes in any state in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of such state. The offering of
these securities is being made only by means of a base prospectus (as supplemented and amended from
time to time), which is part of a registration statement that Medtronic filed with the SEC
utilizing a shelf registration process (collectively, the Prospectus). Copies of the Prospectus
may be obtained from Medtronic Inc. at 710 Medtronic Pkwy NE LC-480, Minneapolis, MN 55432, Attn:
Investor Relations Department, (763) 505-2692.
About Medtronic
Medtronic, Inc., headquartered in Minneapolis, is the worlds leading medical technology company,
alleviating pain, restoring health and extending life for people with chronic disease.
This press release contains forward-looking statements regarding our intended use of proceeds and anticipated use of our shelf registration statement, which are subject to risks and
uncertainties, such as our ability to market and sell the Notes, our continued eligibility to use
the shelf registration statement, general economic conditions and other risks and uncertainties
described in Medtronics filings with the Securities and Exchange Commission. Actual results may
differ materially from anticipated results. Medtronic does not undertake to update its
forward-looking statements.
-end-